Skip to content

Social Inequalities in the Participation and Activity in Children and Adolescents With Hodgkin-lymphoma

Social Inequalities in the Participation and Activity in Children and Adolescents With Hodgkin-lymphoma. A Prospective Multicenter Cohort Study of Social and Personal Influencing Factors

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02808520
Enrollment
700
Registered
2016-06-21
Start date
2016-03-31
Completion date
2020-02-29
Last updated
2016-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Classical Hodgkin Lymphoma

Keywords

Social participation, Children and adolescents with cancer, Quality of life with hodgkin-lymphoma, Social inequalities and cancer

Brief summary

Purpose of this study is to determine the influence of social factors on participation and activity among children and adolescents aged 10-18 years with hodgkin-lymphoma. Furthermore personal and treatment-related factors and their impact on participation will be explored.

Detailed description

Hodgkin-lymphoma is a rare malignancy among children and adolescents (about 140 each year in Germany) which is highly curable. Beside this therapeutic success, a lot of therapy-related long-term problems arise (e.g. fertility disorders, thyroid diseases, secondary malignancies). While most of the studies focused on mental and physical impairments, little attention has been drawn to social dimensions of health. Due to the disease and the requirements of the therapy, participation of children with hodgkin-lymphoma can be impaired acutely or chronically. This can be of serious consequences, because participation in daily life is an important component of the development of children and adolescents. To determine the influence of social, personal and treatment-related factors on participation, all patients who were actual treated in the international therapy study EuroNet-PHL-C2 in all of Germany (N ≈ 700) and their parents will be interviewed. Statistical analyses will be done using descriptive and multivariate methods taking account of treatment-related issues (e.g. stage of disease, chemotherapy, radiotherapy, progression/relapse).

Interventions

None listed

Sponsors

German Cancer Aid
CollaboratorOTHER
University of Giessen
CollaboratorOTHER
Martin-Luther-Universität Halle-Wittenberg
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* histologically confirmed primary diagnosis of classical Hodgkin's Lymphoma * 10-18 years * written informed consent of the patient and/or the patient's parents or guardian according to national laws

Exclusion criteria

* other (simultaneous) malignancies

Design outcomes

Primary

MeasureTime frameDescription
Social participationone month after diagnosis until two yearsThe Child and Adolescent Scale of Participation, CASP
Quality of lifeone month after diagnosis until two yearsQuestionnaire to assess Health Related Quality of Life in chronically ill Children and Adolescents, KINDL

Secondary

MeasureTime frameDescription
Optimismone month after diagnosis until two yearsSubscale from The Bern Subjective Well-Being Questionnaire for Adolescents, BFW
Copingone month after diagnosis until two yearsCoping Questionnaire for Children and Adolescents, CODI
Sense of coherenceone month after diagnosis until two yearsChildren Sense of Coherence Scale, C-SOC
Behavioural disorders and strengthsone month after diagnosis until two yearsStrengths and Difficulties Questionnaire, SDQ
Fatigueone month after diagnosis until two yearsSubscale Fatigue from the Questionnaire to assess Quality of Life of Cancer Patients developed by the European Organisation for Research and Treatment of Cancer, EORTC QLQ-C30
Satisfaction with treatmentone month after diagnosis until two yearsQuestionnaire to assess the Satisfaction with the Treatment, FBB
Social supportone month after diagnosis until two yearsSocial Support Scale, SSS
Understanding of illnessone month after diagnosis until two yearsIllness Perception Questionnaire, IPQ
Autonomyone month after diagnosis until two yearsSubscale Autonomy from the Health-Related Quality of Life Questionnaire for Children and Adolescents, Kidscreen
Self-efficacyone month after diagnosis until two yearsSelf-Efficacy for Managing Chronic Disease 6-Item Scale, SES6

Other

MeasureTime frameDescription
Psychosocial needsone month after diagnosis until two yearsShort-Form Supportive Care Needs Survey Questionnaire, SCNS-SF34 (parental questionnaire)
Use of psychosocial care servicesone month after diagnosis until two years(parental questionnaire)
Satisfaction with treatmentone month after diagnosis until two yearsQuestionnaire to assess the Satisfaction with the Treatment, FBB (parental questionnaire)
Parental coping with chronic childhood diseaseone month after diagnosis until two yearsCoping Health Inventory for Parents, CHIP (parental questionnaire)
Family atmosphereone month after diagnosis until two yearsFamily Environment Scale, FES (parental questionnaire)
Consequences of chronic conditions and disability in childhood and adolescence for the familyone month after diagnosis until two yearsImpact on Family Scale in Families with Children with Disabilities, FaBel (parental questionnaire)

Contacts

Primary ContactJulia Roick, MSc
julia.roick@medizin.uni-halle.de+49 345 557 1136

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026